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Background: In this study we investigated the ability of PEG functionalized gold nanoparticles 11 
as non-viral vectors in the transfection of different cell lines, comparing them with commercial 12 
lipoplexes.  13 
Methods: Positively charged gold nanoparticles were synthesized using PEI as reducing and 14 
stabilizer agent and its cytotoxicity reduced by its functionalization with PEG. We bound the 15 
nanoparticles to three plasmids with different sizes (4-40 kpb). The vector internalization was 16 
evaluated by confocal and electronic microscopy. Its transfection efficacy was studied by 17 
fluorescence microscopy and flow cytometry. The application of the resulting vector in gene 18 
therapy was indirectly evaluated using ganciclovir in HeLa cells transfected to express the 19 
herpes virus thymidine kinase.  20 
Results: An appropriate ratio between the nitrogen from the PEI and the phosphorous from 21 
the phosphate groups of the DNA together with a reduced size and an elevated electrokinetic 22 
potential are responsible for an increased nanoparticle internalization and enhanced protein 23 
expression when carrying plasmids of up to 40kbp (plasmid size close to the limit of the DNA-24 
carrying capacity of viral vectors). Compared to a commercial transfection reagent, an equal or 25 
even higher expression of reporter genes (on HeLa and HEK 293T) and suicide effect on HeLa 26 
cells transfected with the herpes virus thymidine kinase gene were observed when using this 27 
novel nanoparticulated vector. 28 
Conclusions: Non-viral vectors based on gold nanoparticles covalently coupled with 29 
polyethylene glycol (PEG) and Polyethylenimine (PEI) can be used as efficient transfection 30 
reagents showing expression levels same or greater than the ones obtained with commercially 31 
available lipoplexes. 32 
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Introduction 35 
Nanoparticle-mediated transfection is characterized by a reduced immunogenicity and a low 36 
production cost, and an easy and scalable synthesis process compared to the highly efficient 37 
viral vectors (i.e., adenovirus, retrovirus, etc.). Endosomal escape, oligonucleotide protection 38 
and efficient condensation and intracellular unpacking are the main drawbacks to overcome 39 
when designing nanoparticulated transfection reagents. Not only nanoparticle diffusion but 40 
also sedimentation influences cellular uptake which represents a very important parameter to 41 
consider when carrying out in vitro studies1. However, cellular uptake depends mainly on the 42 
oligonucleotide loading on the surface of the nanoparticulated carrier2. Gilleron et al.3 43 
demonstrated in vitro and in vivo that only a small fraction of the siRNAs was able to escape 44 
from the endosomes into the cytosol, when using lipid nanoparticles as short interfering siRNA 45 
delivery vectors. This gene delivery efficiency can be improved by promoting endosomal 46 
escape and by protecting the oligonucleotide from intra and extracellular degradation. Drugs, 47 
peptides, lipids and cationic polymers have been added to nanoparticle-based formulations to 48 
promote this endosomal escape4.The protection of the oligonucleotide of interest against 49 
enzymatic nuclease degradation can be carried out by encapsulation inside the 50 
nanoparticulated system5 or by means of layer-by-layer assembly of alternate polyelectrolytes 51 
on the surface of the nanoparticles together with the plasmid or siRNA6. Finally, direct covalent 52 
coupling of the oligonucleotide to the nanoparticle reduces the susceptibility to nuclease 53 
degradation when the bond does not impair the oligonucleotide biological activity7. Those 54 
benefits have supported several clinical trials using nanoparticles transporting plamids8 and 55 
siRNAs9 suppressing or silencing genes involved in cancer proliferation. 56 
Rosi et al.7 demonstrated that with the same amount of antisense oligonucleotide transported, 57 
gold nanoparticles can outperform the silencing efficiency in terms of protein percent 58 
knockdown compared to different commercially available transfection reagents with no signs 59 
of cytotoxicity at the doses tested. Lee et al.10 described the gene silencing efficiency of 60 
cysteamine modified gold nanoparticles decorated with PEI and targeted using hyaluronic acid 61 
using luciferase-specific siRNA and vascular endothelial growth factor-specific siRNA in the 62 
presence of 50 vol % serum to simulate in vivo conditions. Under those conditions, a 70% 63 
reduction of the VEGF mRNA level was measured for the nanoparticulated vector whereas only 64 
a 20% reduction was observed for the commercial lipofectamine used as control. Simultaneous 65 
co-delivery of si-RNA and plasmidic DNA for knockdown and expression was demonstrated by 66 
Bishop et al.11 using polymer-coated (by layer-by-layer) gold nanoparticles with superior 67 
performance compared to commercially available transfection reagents at the same dosages in 68 
human brain cancer cells. 69 
However, even with higher transfer efficiency, strategies designed to improve the 70 
oligonucleotide penetration and lower cytotoxicity are highly desired. To do so, strategies 71 
using copolymers based on PEI (polyethylenimine) and PEG (polyethylene glycol) and linked 72 
with cell penetrating peptides (i.e., trans-activating transcriptional activator TAT) have been 73 
widely used as transfection reagents12. For those polyplexes appropriate sizes (between 50 and 74 
75 nm) and PEI nitrogen to DNA phosphates ratios (30-40) are critical to achieve high 75 
transfection efficiency12. The use of PEI and PEG as transfection reagents has also been 76 
previously combined with magnetic nanoparticles. The conjugation of PEI to nanoparticles 77 
favors DNA sedimentation and cellular uptake and enhances the transfection efficiency13. In 78 
this regards Stephen et al.14 have recently showed the use of chitosan-PEG grafted with 79 
catechol functionalized with cationic polyethylenimine on the surface of magnetic 80 
nanoparticles. However, the transfection efficiency was reduced when PEG was used to reduce 81 
the cytotoxicity of the transfection reagent. In addition, PEG and PEI have also been grafted on 82 
the surface of carbon nanotubes15 and graphene16 to silence target gene expression via RNA 83 
interference taking advantage of the improved solubility provided by the PEG.  84 
In general PEG reduces non-specific interactions with plasma proteins and nanoparticle-cell 85 
internalization with the consequent reduction in the transfection efficacy. Many PEG de-86 
shielding strategies have been implemented to release the plasmid in vivo under the 87 
intracellular reductive conditions17,18. Williams et al.19 demonstrated in vivo that neither the 88 
covalent coupling nor the electrostatic interaction of gold nanoparticles to PEI/PEG increased 89 
the transfection efficiency and protein expression compared to the levels achieved with the 90 
PEI/PEG polyplexes alone. The authors postulated that the electrostatic interaction was not 91 
stable enough during the delivery and for the case of the covalently grafted PEI/PEG, a low 92 
nanoparticle to PEI/PEG ratio might be responsible for such a reduced transfection efficiency.  93 
Here, we present a transfection reagent based on gold nanoparticles and PEG/PEI in which the 94 
transfection efficiency levels reached are equivalent or even superior in some conditions to 95 
commercially available transfection reagents using 3000, 4700 and up to 40000 base pairs 96 
plasmids, the later being close to the limit of the DNA-carrying capacity of viral vectors20.  97 
 98 
Materials and Methods 99 
Nanoparticle Synthesis and Characterization 100 
Au-PEI nanoparticles were synthesized using Polyethylenimine (PEI) branched (≈25 kDa, Sigma 101 
Aldrich) as reductant and stabilizer. Briefly, 1mL of a 0.5 x 10-3 M PEI solution was added to 19 102 
mL of a solution of 50 mgL-1 of HAuCl4 at room temperature under vigorous stirring. The 103 
resulting Au-PEI nanoparticles were dialyzed (50 kDa cut-off) against distilled water in order to 104 
eliminate the unbounded PEI. Those nanoparticles were subsequently bound to poly-ethylene 105 
glycol (PEG) by using an excess of monofunctional poly(ethylene glycol)methyl-ether-thiol 106 
(PEG, 800 Da MW Sigma Aldrich). Any excess of unbound PEG was removed by dialysis (14 kDa 107 
cut-off). 108 
Preliminary electron microscopy observations were carried out in LMA-INA-UNIZAR using a 109 
T20-FEI microscope with a LaB6 electron source fitted with a “SuperTwin®” objective lens 110 
allowing a point-to-point resolution of 2.4 Å. Aberration corrected scanning transmission 111 
electron microscopy (Cs-corrected STEM) images were acquired using a high angle annular 112 
dark field detector in a FEI XFEG TITAN electron microscope operated at 300 kV equipped with 113 
a CETCOR Cs-probe corrector from CEOS Company allowing formation of an electron probe of 114 
0.08 nm. The geometric aberrations of the probe-forming system were controlled to allow a 115 
beam convergence of 24.7 mrad half angle to be elected. Phosphotungstic acid was used to 116 
visualize PEG and PEI functionalization. The zeta potential and the particle-size distribution 117 
were measured by dynamic light scattering (DLS) at pH=7 in a Brookhaven 90 Plus equipment 118 
using the ZetaPals software. Also UV-visible spectroscopy (Jasco V670) was used for the 119 
nanoparticle extinction spectrum evaluation. The bond between PEI, Au and PEG was studied 120 
by Fourier transform infrared spectroscopy. Nitrogen (from PEI) to phosphorous (from 121 
phosphate groups in the DNA) ratios were calculated using X-Ray photoelectron spectroscopy 122 
(XPS) by using an Axis Supra (Kratos Analytical, UK). A monochromatic Al Kα X-ray radiation (hν 123 
= 1486.6 eV) was used as excitation source at 15 kV and 15 mA. The peaks analysis was 124 
developed by the CasaXPS software (Casa Software Ltd, UK). In this analysis, the core level P 125 
2p3/2 centered at 133.4 eV was attributed to the phosphate groups in the DNA in agreement 126 
with the previous literature22. 127 
NPs/DNA complex formation and agarose gel electrophoresis retention assay 128 
Au-PEI and Au-PEI-PEG nanoparticles were complexed with DNA at different µg NPs/µg DNA 129 
weight (w/w) ratios. The amount of DNA was kept constant (1 µg) and the nanoparticle mass 130 
was varied from 10 to 50 µg in a final volume of 50 µL. The complexes were incubated for 30 131 
min at room temperature. The DNA binding ability of the NPs was evaluated by using the 132 
agarose gel electrophoresis retention assay. The loading buffer was mixed with the complexes 133 
before adding them into 1% agarose gel containing SYBR® Safe stain. After running the gel at 134 
60V for 40 min, the migration of plasmidic DNA was visualized in a UV chamber (Biorad 135 
ChemiDoc RXS). Moreover, the DNA/NPs binding ability was analyzed measuring the surface 136 
charge of the complexes by DLS in a Brookhaven 90 Plus apparatus. 137 
In order to study the DNA protection capacity of the nanoparticles, the Au-PEI or Au-PEI-138 
PEG/DNA complexes were incubated with NotI and XhoI restriction enzymes during 1 hour at 139 
37°C. The resulting digestion was added into a 1% agarose gel containing SYBR® Safe stain and 140 
ran at 60V for 40 min. The migration of the fragment was visualized in a UV chamber (Biorad 141 
ChemiDoc RXS). 142 
AFM analysis 143 
AFM measurements were made in liquid phase by the Quantitative Nanomechanical 144 
Measurement Peakforce intermittent contact technique, in a Multimode 8 (Bruker Co.). The 145 
applied force was 1nN and the tip used was a commercial tip (Bruker, SNL model, type – C), 146 
with a hardness around 0.5N/m. 147 
Cell culture and nanoparticle cytotoxicity evaluation 148 
HeLa and HEK 293T cells were obtained from Cancer Research UK Culture Collection. Both 149 
types of cells were cultured in Dulbecco’s modified Eagle’s (DMEM) with 10% fetal bovine 150 
serum (FBS, GIBCO), 1% penicillin/streptomycin and 1% amphotericin and maintained at 37°C 151 
in a 5% CO2-humidified incubator. For the cytotoxicity experiments HeLa and HEK 293T cells 152 
were seeded onto 96 multi well plates at 5 x 103 or 1 x 104 cells per well, respectively. The 153 
toxicity of the different vectors (Au-PEI and Au-PEI-PEG nanoparticles) was evaluated by the 154 
AlamarBlue® assay after 24 hours of incubation for different nanoparticle concentrations (12,5 155 
µg mL-1 to 100 µg mL-1). 156 
Confocal microscopy 157 
In order to assess the intracellular trafficking of the reporter gene pEGFP, confocal microscopy 158 
was used. The pEGFP was labeled with Laber IT® µArray Cy5 (Mirus) according to the 159 
manufacturer’s indications. For the DNA internalization assay cells were cultured on sterile 160 
cover slips at 2 x 104 cells per dish before running confocal microscopy analysis. For that 161 
purpose, 1 µg of labeled-pEGFP was complexed with 20 or 30 µg of Au-PEI-PEG nanoparticles 162 
or with 3µL of Lipofectamine® 2000 in 50 µL of DMEM. The complexes were incubated with 163 
cells during 4 hours. Afterwards, cells were washed with PBS twice and fixed with 4% para-164 
formaldehyde during 20 min, followed by staining with phalloidin 488 to label the actin fibers 165 
and the cell nucleus with DAPI. The intracellular localization of the resulting complexes inside 166 
the cells was verified by using an Olympus Compact Type Oil FV10i confocal microscope.  167 
Transfection assays 168 
Three different plasmids were conjugated to Au-PEI-PEG nanoparticles:  pEGFP, pΔdTL and 169 
pTK. pEGFP-N1 (Clontech Laboratories Inc.) is a 4.7 kbp plasmid that encodes the green 170 
fluorescence protein under the CMV promoter. The ΔdtL was kindly provided by Ramón 171 
Alemany (Bellvitge Biomedical Research Institute, Spain), this 41.9 kbp plasmid has the 172 
inactivated genome of an oncolytic virus but also encodes a green fluorescence protein23. pTK 173 
was given by Jon Schoorlmmer (Fundación Araid, Spain). This 5 kbp expression vector encodes 174 
the herpes simplex virus thymidine kinase gene under the control of the thymidine kinase 175 
promoter. EGFP and ΔdtL transfection efficiencies were evaluated by fluorescence microscopy, 176 
whereas EGFP expression was also quantified by flow cytometry. In addition, TK expression 177 
was indirectly measured studying the Ganciclovir cytotoxic effect in transfected cells, as it is 178 
the prodrug that activates the TK´s suicide effect. In all cases the ratio between NPs and DNA 179 
was 20:1 and 30:1 w/w. 180 
To carry out the fluorescence microscopy experiments, cells were seeded onto 96 multi well 181 
plates at the densities mentioned above.  125 or 250 ng of pEGFP or pΔdTL were added to 182 
each well. First of all, the Au-PEI-PEG nanoparticles/DNA (20:1 and 30:1 w/w) or 183 
Lipofectamine/DNA complexes were incubated with HeLa or HEK 293T cells during 24 or 48 184 
hours. In the case of Lipofectamine® the culture medium was changed 4 hours after its 185 
addition, and the Lipofectamine/DNA relation was 3:1 (v/w), as it is normally indicated for our 186 
cell types. The green fluorescence was visualized using an Olympus IX81 inverted fluorescence 187 
microscope. For the evaluation of the transfection efficiency using cytometry, cells were 188 
seeded onto 6 multi well plates (1 x 105 cells per well). The transfection efficiency was 189 
evaluated by flow cytometry using a FACSAria separator cytometer (BD) under a 488 nm laser 190 
excitation. Cells were incubated with Au-PEI-PEG nanoparticles/DNA or Lipofectamine/DNA 191 
complexes during 24 h or 48 h. Also in this case the medium of the cells treated with 192 
Lipofectamine® was changed after 4 h. At the desired time points cells were harvested and 193 
EGFP expression quantified.  194 
To follow up the transfection effects with the plasmid encoding the thymidine kinase gene, 195 
cells were incubated with the complexes during 24 hours. Then, DMEM containing 1 mg mL-1 196 
of Ganciclovir ((GCV), Sigma) was added to the cellular cultures. GCV is a pro-drug which exerts 197 
antiproliferative effects in cells that express the thymidine kinase gene. Both types of cells 198 
(HeLa and HEK 293T) were incubated with this GCV medium for 72 hours. Afterwards, an 199 
AlamarBlue® assay was performed in order to analyze the cellular viability. 200 
Transmission electron microscopy 201 
In order to study the intracellular localization of Au-PEI and Au-PEI-PEG nanoparticles, HeLa 202 
cells were seeded at a 1 x 106 cell per plate density onto a t75 flask and cultured for 24 hours. 203 
At that time point a dispersion of DMEM containing 10 µg mL-1 of Au-PEI or Au-PEI-PEG 204 
nanoparticles in a final volume of 10mL, was added to the culture. Cells were incubated with 205 
this dispersion during 24 hours. After that time cells were washed twice with PBS and 206 
trypsinized.  The cellular pellet was fixed with 2,5% glutaraldehyde during 1h and washed again 207 
twice with PBS. A post-fixation was performed for 1,5 h in 1% osmium tetroxide at room 208 
temperature. The samples were washed several times before their dehydration in graded 209 
series of ethanol (30, 50, 70, 95 and 100 vol.%) and propylene oxide. Both samples were then 210 
embedded in Durcupan (Fluka, Sigma). Sections with a thickness of about 60 nm were 211 
mounted on nickel grids before their examination by a T20-FEI microscope and by a FEI Titan 212 
Cube 60-300 TEM operating in a STEM-HAADF mode. 213 
Statistical analysis 214 
Results are expressed as mean ± SD. Statistical analysis was performed with the STATA 215 
Software. Student’s t-test was used to assess statistical differences (p<0.05) between groups 216 
with normal distribution and Kruskal-Wallis (p<0.05) between groups with non-normal 217 
distribution. 218 
Results  219 
Nanoparticle synthesis and characterization 220 
Figure 1 describes the morphology of the nanoparticulated gene carriers here described. DLS 221 
measurements revealed a hydrodynamic size distribution centered at 11,1 ± 2 nm and 222 
histograms retrieved from the TEM size analysis on dried samples (11,3 ± 2 nm) corroborated 223 
those sizes. The polycrystalline structure of the nanocrystals can be observed in the HRTEM 224 
images. Also an organic halo around the nanoparticles is indicative of the presence of the 225 
polymeric PEI and PEG corona. The colloidal Au-PEI-PEG nanoparticles in water show a 226 
maximum UVVIS extinction peak at around 520 nm (Figure S1). This absorption is characteristic 227 
of the localized surface plasmon resonance peak of spherical gold nanocrystals due to the gold 228 
interband transitions reached when the value of the real part of the dielectric function of the 229 
particle material equals two times the dielectric constant of the solvent (water)24. The high 230 
extinction at low wavelengths observed is caused by the scattering of the samples. Zeta 231 
potential analysis revealed a positive charge for the colloidal Au-PEI-PEG nanoparticles, 232 
electrokinetic potential which was reduced after plasmid DNA (pEGFP) grafting but still 233 
positive to be able to electrostatically interact with the negatively charged cell surface 234 
glycoproteins. A reduced size (~5 times less) and higher zeta potential (~3 times more) was 235 
observed for the Au-PEI-PEG nanoparticles compared to Lipofectamine® 2000 after DNA 236 
coupling. 237 
Figure 1. Au-PEI and Au-PEI-PEG nanoparticle characterization. a)Au-PEI (left) and Au-PEG-PEI (right) 238 
nanoparticles TEM images (above) and  STEM-HAADF image (bottom). The PEG corona is visible because 239 
of the phosphotungstic acid staining (right). b) DLS analysis. Size of Lipofectamine and the nanoparticles 240 
incubated with pEGFP. Zeta potential of the Au-PEI-PEG nanoparticles before and after GFP plasmid 241 
coupling. The Z potential was measured at pH=7 in distilled water.  242 
FTIR analysis (Figure SI1) was performed to evaluate the successful covalent coupling between 243 
the SH-PEG and the gold nanoparticles and also to corroborate the presence of the amino 244 
groups introduced by the PEI. SH-PEG exhibits the S–H stretching vibrational mode appearing 245 
at around 2557 cm−1. As expected, subsequent to its reaction with Au-PEI nanoparticles, the S–246 
H bond stretching vibrational band completely disappeared which indicated the formation of 247 
the S–Au bond25. This S–Au interaction is partially covalent (~35%) and mostly electrostatic 248 
(~65%)26. N–H bending and C–N stretching modes were observed near 1594 and 1120 cm–1, 249 
respectively. CH2 bending modes and C–C stretching modes were also observed at 1454 and 250 
1047 cm–1, respectively. Two N–H stretching modes were detected for the primary amine 251 
group near 3355 and 3277 cm–1, and an overtone band near 3180 cm–1 was also present. The 252 
characteristic C–H stretching modes were observed between 3000 and 2700 cm–1, with the 253 
most intense band being centered near 2805 cm–1. For Au-PEI nanoparticles the relative 254 
intensity of the C–N stretching mode was diminished relative to that of the C–C stretching 255 
modes.  256 
XPS analysis (Table SI1) also revealed the presence of phosphorus on the Au-PEI-PEG 257 
nanoparticles incubated with the DNA, revealing a N/P from phosphate ratio of 40,6 (Table 258 
SI1). This high ratio is a guarantee of a successful transfection in agreement with the previous 259 
literature12,13,27.  260 
 261 
 262 
DNA-nanoparticle complex formation and cytotoxicity evaluation 263 
The agarose gel electrophoresis assay demonstrated nanoparticle/DNA electrostatic 264 
complexation (Figure 2). A constant amount of different plasmid DNA was complexed with Au-265 
PEI or Au-PEI-PEG nanoparticles at different ratios of 50:1, 40:1, 30:1, 20:1 and 10:1 266 
(nanoparticles:DNA). Maximum fluorescence signals were detected for the 20:1 and 30:1 267 
samples, whereas at higher nanoparticle loadings the band was not clearly observed, probably 268 
caused by the fluorescence quenching by nanoparticle agglomeration in agreement with the 269 
previous literature27. In order to demonstrate the presence of the DNA, we use, as control, a 270 
1:1 ratio of NPs:DNA (Figure SI2). In that large DNA excess, the genetic material was not totally 271 
bound to the NPs, and a free DNA band was observed. Three different plasmids of different 272 
number of base pairs (3000, 4700 and up to 40000 kbp) were successfully complexed by the 273 
Au-PEI-PEG nanoparticles and no signs of plasmid fragmentation was observed. 274 
Subcytotoxic doses for the Au-PEI and Au-PEI-PEG nanoparticles were evaluated on different 275 
cell lines (HeLa and Hek293t) evaluating the resazurin colorimetric change in response to the 276 
cellular metabolism (Figure 2). Following the recommendations of the ISO 10993-5 in which 277 
viabilities higher than 70% are not considered cytotoxic we proposed the use in vitro of Au-PEI-278 
PEG nanoparticles at doses up to 50 µg/mL on Hek293t cells and up to 25 µg/mL on HeLa cells. 279 
Our results indicated that doses below 12,5 µg/mL could be potentially used for transfection 280 
applications on those cell lines when using just Au-PEI nanoparticles. Clearly PEGylation 281 
reduced PEI cytotoxicity in agreement with the literature28, probably caused by a reduced cell 282 
internalization.  283 
Figure 2. Biological characterization of Au-PEI and Au-PEI-PEG nanoparticles. a) Agarose gel 284 
electrophoresis for different Au-PEI and Au-PEI-PEG/plasmid ratios (w/w) The amount of DNA was kept 285 
constant and the amount of nanoparticles was increased from 10 to 50 µg. b) Cytotoxicity evaluation of 286 
Au-PEI an Au-PEI-PEG nanoparticles in HeLa and HEK 293T cells by using the AlamarBlue assay. The 287 
toxicity was calculated relative to an untreated control for which 100% viability was set. 288 
We also analyzed the DNA protection from degradation by using a gel retardation assay. Naked 289 
DNA showed degradation after treatment with the XhoI and NotI restriction enzymes (Figure 290 
SI3). In contrast, no significant loss of plasmid integrity was observed for the nanoparticulated 291 
complexes, indicative of a successful DNA condensation and protection in the polymeric 292 
nanoparticle corona. DNA condensation was also corroborated by AFM (see Figure SI4) where 293 
a slight nanoparticle size increase was observed for the Au-PEI-PEG nanoparticles after DNA 294 
coupling and no free DNA was observed.  295 
Transfection efficiency  296 
We observed how GFP expression was qualitatively enhanced when using both Au-PEI-PEG 297 
20:1 and 30:1 (w/w) transfection reagents compared to the commercial liposomal formulation 298 
(Figure 3) in both HeLa and Hek293t cell lines. Bright field images show that the morphology of 299 
the cell lines was not altered by the presence of the nanoparticles. HeLa cells remained 300 
elongated, growing adherently with epithelial morphology. Hek293t cells also remained 301 
unaltered showing an epithelial adherent morphology. 302 
Figure 3. pEGFP transfection evaluation by fluorescence microscopy in HeLa and HEK 293T cells. GFP 303 
fluorescence was evaluated at 488/520 nm excitation/emission. All the images were acquired with the 304 
10X objective 24 h after the addition of the complexes in a fluorescence inverted microscopy Olympus 305 
IX81. Scale: 200 micron. Cells not incubated with any vector were used as negative control, while cells 306 
incubated with Lipofectamine/pEGFP complexes were used as positive control. 307 
Figure 4 shows the fluorescence quantification by flow cytometry from cells expressing the 308 
gene for green fluorescent protein (GFP) using the nanoparticles and the commercial 309 
Lipofectamine® 2000. Similar results were obtained 24h after transfection but 48h later the 310 
green fluorescence intensity was higher (p<0.05) when using Au-PEI-PEG nanoparticles 311 
compared to the control. The percentage of GFP positive cells 48 h after the addition of the 312 
complexes was approximately a 15% higher for the 20:1 ratio than for the Lipofectamine-313 
based control and for the 30:1 ratio, the percentage of GFP positive cells 48 h after the 314 
addition of the complexes was a 20% higher than that obtained for the control. 315 
Figure 4. Fluorescence quantification by flow cytometry in HeLa and HEK 293T cells. The cytometry 316 
graphs show the GFP positive cells at 48 h.  Statistically significant differences are labelled with *. (p< 317 
0.05). Positive control represents the use of Lipofectamine® 2000. Cells not incubated whit any vector 318 
were used as negative control. 319 
A successful transfection was even achieved using the Au-PEI-PEG nanoparticles as gene 320 
carriers of a 40000 base pairs plasmid (Figure 5). Qualitatively a higher transfection was 321 
achieved when using the gold-based nanocarriers. The transfection efficiency of large plasmids 322 
is limited by the slow transit through the intracellular vesicles by molecular crowding and small 323 
plasmids are usually diffusing faster towards the nuclei29,30.  324 
 325 
 326 
Figure 5. pΔdTL transfection evaluation by fluorescence microscopy on HEK 293T cells.  The images were 327 
taken in a fluorescence inverted microscopy Olympus IX81. All the images were acquired with the 10X 328 
objective 24 h after the addition of the complexes. In these cases two amounts of DNA were tested: 125 329 
and 250 µg per well. Scale bar: 200 micron. Cells not incubated with any vector were used as negative 330 
control, while cells incubated with Lipofectamine/pΔdTL complexes were used as positive control. 331 
As one of the main purposes of this strategy would be the use of those NPs as vectors for gene 332 
therapy, we performed a classical approach of suicide gene therapy mediated by the Herpes 333 
Simplex virus thymidine kinase gene triggered by the prodrug Ganciclovir. The gene product 334 
phosphorylates the nontoxic GCV into GCV triphosphate, which is incorporated into DNA in 335 
replicating cells, inhibiting DNA synthesis and resulting in cell death31. Figure 6 shows the 336 
enhanced transgene efficient delivery when using the Au-PEI-PEG nanoparticles compared to 337 
the use of the commercial formulation. 338 
Figure 6. Cell viability using the thymidine kinase suicide gene under the presence of GCV in HeLa cells. 339 
Phosphorilated GCV is able to mediate the cell death at the doses studied. In the maximum nanoparticle 340 
concentration the high presence of Au-PEI-PEG nanoparticles promote some death in the absence of 341 
GCV. 342 
Intracellular trafficking was monitored using Cy5 labeled-pEGFP complexed with either Au-PEI-343 
PEG nanoparticles or with Lipofectamine® 2000. As can be seen in Figure 7, after 4 hours of 344 
incubation complexes were visible in the cytoplasm of the HeLa cells. The presence of 345 
lipofectamine/Cy5-DNA complexes in the extracellular matrix clearly indicated the presence of 346 
larger agglomerates compared to the ones observed when using the nanoparticulated gene 347 
carriers. The orthogonal projections of the confocal images clearly show that some labeled 348 
plasmids are located inside of the nuclei of the cells.  The internalization of types of 349 
nanoparticles was also evaluated by HRTEM in HeLa cells. Figure 8 shows the intracellular 350 
distribution of both types of nanoparticles inside the cell cytosol. After 24 h of incubation, the 351 
nanoparticles were accumulated forming aggregates within intracellular vesicles without 352 
reaching the cellular nucleus. 353 
Figure 7. Internalization complexes evaluation by confocal microscopy. Intracellular trafficking of 354 
fluorescently (Cy5) labeled GFP plasmid bound to either Lipofectamine® or Au-PEI-PEG nanoparticles 355 
after 4 hours of incubation. HeLa cells were fixed and visualized by confocal microscopy. Actin fibers are 356 
shown in green and nuclei in cyan. The labelled plasmid DNA is shown in blue. Scale: 20 micron. 357 
 358 
 359 
Figure 8. Internalization nanoparticle evaluation by TEM. Intracellular internalization of Au-PEI (above) 360 
and Au-PEI-PEG (bottom) nanoparticles evaluated by STEM-HAADF. HeLa cells were incubated with Au-361 
PEI (above) or Au-PEI-PEG (bottom) during 24 h, the arrows indicate the presence of the nanoparticles 362 
and their intracellular presence within vesicles. The presence of gold was confirmed in both cases by 363 
EDX analysis. 364 
Discussion 365 
The transfection efficiency of nanoparticulated carriers can be improved when combining an 366 
adequate electrokinetic potential, able to electrostatically bind condensed DNA, with 367 
appropriate gene-vector dispersion and reduced agglomeration in the culture media. PEI 368 
provides with the surface charge needed for a successful transfection due to its large buffering 369 
and endosomolytic ability and PEG provides with a reduced unspecific adsorption and steric 370 
hindrance. However this PEI buffering ability and consequent change in the endosomal pH is 371 
still a matter of debate32 and probably its degradative action on the pH-dependent endosomal 372 
compartment is responsible for the DNA release. Despite the successful transfection efficiency 373 
of PEI, this cationic macromolecule acts as an apoptotic agent disrupting the plasma 374 
membrane and altering the mitochondrial membrane33. As we mentioned before, PEG has 375 
been introduced in PEI-based vectors to improve their solubility and to reduce their 376 
cytotoxicity but with the main drawback of reducing the efficiency compared to the one 377 
achieved with the non-PEGylated vector. The reduction in the cytotoxicity induced by the PEG 378 
is attributed to its mitigation ability to the charge-induced toxicity14. This charge reduction 379 
decreases the PEI buffering ability and also the successive washing steps followed to anchor 380 
PEG on the PEI-based vector contribute to remove unbound PEI which contributes to an 381 
efficient gene expression34. We clearly demonstrate (Figure 3) that PEG reduces the PEI 382 
cytotoxicity probably caused by a reduction in the negative charge considering that the 383 
electrokinetic potential of Au-PEI in water was +30,4±0,8 mV and after PEG grafting the Au-PEI-384 
PEG nanoparticles showed a zeta potential of +26,2 ± 2,4 mV (Figure 1). Enzymatic degradation 385 
is not responsible for a successful gene transfer carried out by the nanoparticulated systems.  386 
We observed that no significant loss of plasmid integrity was observed after treating the 387 
nanoconjugated plasmids with restriction enzymes. This is an indication that just PEI is a 388 
successful reagent to condense plasmid DNA protecting it from degradation in the cytosol by 389 
achieving a more stable form and with longer retention times than free DNA35. It has been 390 
postulated that PEI offers a steric and/or electrostatic barrier to the diffusion of the restriction 391 
enzyme towards the protected DNA36. The different transfection levels achieved for the two 392 
cell lines tested might be attributed to the different cell-specific intracellular barriers for the 393 
plasmid to overcome and to the different transcription efficiency and consequent protein 394 
expression. It has been reported that Hek293t cells exhibit the highest level of PEI-mediated 395 
GFP transfection with 50-80% of cells showing protein expression37. The obtained gene 396 
expression levels on HeLa cells were lower than the ones obtained with Hek293t cells (Figures 397 
3 and 4), which can be attributed to the higher cytotoxicity of the Au-PEI-PEG nanoparticles on 398 
the HeLa cells at the same doses (Figure 3). In addition, the 293t cell line contains the SV40 399 
Larde T-antigen which allows for episomal replication of transfected plasmids containing SV40 400 
as the pEGFP used in this work29. For that reason the amplification product might have a larger 401 
temporal expression in the Hek293t cell line. 402 
Lukacs et al.38  demonstrated that plasmid DNA with sizes above 250 bp remain almost 403 
immobile in the cytoplasm because of molecular crowding; however PEI has demonstrated 404 
efficient transfection of large plasmids being able to unpack and release the DNA which then 405 
diffuses to the nuclei. Large plasmid DNA (52.5 Kbp) rendered unsuccessful transfection 406 
efficiency when using lipoplexes due to the incipient colloidal instability being the size and 407 
morphology of the polyplex invariant irrespective of the plasmid size30. Viral vectors have been 408 
used linked to PEI to enhance transfection efficiency when using “large” plasmids. In this 409 
regard, 12 Kpb plasmids have been linked to PEI and to an adenovirus for a successful 410 
transfection of human primary myoblasts39. In our work, we demonstrated how qualitatively a 411 
superior gene expression was achieved when using Au-PEI-PEG nanoparticles compared to the 412 
use of the commercial lipoplexe carrying a 40 Kbp plasmid. This efficiency difference might be 413 
attributed to the PEG ability in retarding endosomal escape as previously reported40. 414 
Particle size affects gene expression and a reduced gene vector agglomeration in the culture 415 
media favors DNA internalization. Large agglomerates sediment and interact easily with the 416 
cellular membrane; however larger agglomerates are excluded from the endocytic route and 417 
are usually internalized following macropinocytosis in which the internalized cargo is stored in 418 
the lysosomal compartment41. Therefore, we propose that the lack of large agglomerates with 419 
sizes above 200 nm (which is the optical resolution of the confocal microscope used) are 420 
responsible of a successful transfection efficiency for our Au-PEI-PEG nanocarriers compared 421 
to the Lipofectamine 2000 reagent where clear plasmid agglomerates were observed in the 422 
culture media (Figure 7). 423 
Conclusions 424 
Gold nanoparticles can be used as non-viral vectors for gene expression using PEI as surface 425 
functional agent. PEI condensates and protects the carried plasmid from enzymatic 426 
degradation. The PEGylation of those nanoparticles by covalent coupling reduces the PEI 427 
cytotoxicity as well as enhances nanoparticle dispersion in culture media. Different plasmids 428 
with different number of pair bases can be transfected using this vector and plasmids up to 429 
40kpb can be transfected with a superior performance than the one obtained with 430 
commercially available lipoplexes. Not only reporter genes but also a superior suicide effect in 431 
cells transfected with the herpes virus thymidine kinase gene mediated by ganciclovir was 432 
observed using the nanoparticulated vector. 433 
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Table 1. XPS elemental composition of the Au-PEI-PEG and Au-PEI-PEG-pDNA 573 






































































































































Figure 8. 677 
a) b) c)
e) f) g)

















0 2 4 6 8
U
Os
 
 
In
te
ns
ity
, (
a.
u.
)
Energy, keV
Au
C
O
Os
d)
h)
 678 
 679 
 680 
 681 
 682 
 683 
 684 
 685 
 686 
 687 
 688 
 689 
 690 
 691 
 692 
 693 
